$11.62
0.010.09%
Medifast Inc
MEDNYSE
Medifast (MED) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Medifast (MED) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-1.75 - $-0.25, compared to a consensus EPS estimate of $-1.87. Medifast also guided revenue in the range of $270M - $300M for the period.
Compared to prior guidance, Medifast raised its EPS outlook from a previous range of $-2.75 - $-1.55. On the revenue side, the company maintained its revenue forecast from a prior range of $270M - $300M.
Medifast has issued 19 guidance updates between November 3, 2022 and August 3, 2026. During this period, the company raised its outlook 3 times and lowered it 12 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.66 | $-0.53 | $-0.80 | $-0.22 |
| Actual | $-0.28 | $-0.19 | $-0.55 | $-0.21 |
| Surprise | +57.6% | +64.1% | +31.3% | +4.55% |
| Revenue | ||||
| Estimate | $73.8M | $70.1M | $71.2M | $88.2M |
| Actual | $76.4M | $76.0M | $75.1M | $89.4M |
| Surprise | +3.46% | +8.46% | +5.53% | +1.40% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.13 | $-0.17 | $-0.12 |
| Revenue | ||||
| Consensus | $70.6M | $63.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $-0.28 | $-0.66 | 57.6 % |
| Q1 | May 4, 2026 | $-0.19 | $-0.53 | 64.1 % |
| Q4 | Feb 17, 2026 | $-0.55 | $-0.80 | 31.3 % |
| Q3 | Nov 3, 2025 | $-0.21 | $-0.22 | 4.55 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $76.38M | $73.83M | 3.46 % |
| Q1 | May 4, 2026 | $76.04M | $70.11M | 8.46 % |
| Q4 | Feb 17, 2026 | $75.10M | $71.16M | 5.53 % |
| Q3 | Nov 3, 2025 | $89.41M | $88.17M | 1.40 % |
